Page last updated: 2024-10-22

amitriptyline and Paraganglioma

amitriptyline has been researched along with Paraganglioma in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Paraganglioma: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Phillips, TJ1
Farquhar-Smith, WP1

Other Studies

1 other study available for amitriptyline and Paraganglioma

ArticleYear
Pharmacological treatment of a patient with first-bite syndrome.
    Anaesthesia, 2009, Volume: 64, Issue:1

    Topics: Amitriptyline; Analgesics, Non-Narcotic; Carbamazepine; Cranial Nerve Neoplasms; Drug Therapy, Combi

2009